Search Results 211-220 of 14777 for anti-TNF drugs
The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after progression on LGX818/MEK162 ...
anti-TNF alpha agents) =< 2 weeks prior to randomization, or anticipation of need for systemic immunosuppressive medication during study treatment, with the ...
... anti-rheumatic medication use. We hypothesize that: Patients responding to antirheumatic medication(s) and their combinations share similar phenotype and/or ...
Alkylating agents and anti-tumor antibiotics. There's concern that high doses of vitamin E might affect the use of these chemotherapy drugs. · Anticoagulants and ...
Medicines often are important for treating depression while pregnant. Weigh the risks and benefits with your health care team.
... therapy, and atezolizumab alone for adjuvant therapy. ... Prior systemic anti-cancer therapy for melanoma (e.g., chemotherapy, hormonal therapy ... (TNF)-a agents) ...
Most anti-neoplastic drugs have narrow therapeutic indices. Therefore, treatment with these drugs can result in significant, sometimes, life-threatening ...
... treatment for subjects with persistent atrial fibrillation as compared to subjects who received an initial treatment with anti-arrhythmic drugs.
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Beconase; Beconase AQ; Flonase; Nasacort; Nasalide; Nasarel ...
ustekinumab mono or combination therapy;; patients on mesalamine or no therapy. Group B (Low vaccine responders):. Anti-TNF monotherapy;; anti-TNF combination ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.